Li Ya, Zhang Weifeng, Zhao Junli, Li Sai, Shan Linlin, Zhu Jiuling, Li Yan, Zhu He, Mao Qinwen, Xia Haibin
Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, 199 South Chang'an Road, Xi'an, 710062, Shaanxi, People's Republic of China.
Department of Pathology, Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Ward 3-140, Chicago, IL, 60611, USA.
Cytotechnology. 2018 Dec;70(6):1595-1605. doi: 10.1007/s10616-018-0252-2. Epub 2018 Sep 1.
The clustered regulatory interspersed short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) system has been widely used for gene knock-out. Lentiviral vectors have been commonly used as a delivery method for this system, however, prolonged Cas9/sgRNA expression due to lentiviral integration can lead to accumulating off-target mutations. To solve this issue in engineering a gene knock-out cell line, this study established a novel system, which was composed of two lentiviral vectors. One lentiviral vector carried simultaneously sgRNAs and CRISPR/Cas9 expression cassettes targeting single or multiple gene(s); the other lentiviral vector carried Cre that could remove excess sgRNAs and Cas9 expression cassettes in the genome after gene targeting was achieved. To prove the principle, two candidate genes, extracellular matrix protein 1 (ECM1) and progranulin (PGRN), both highly expressed in MDA-MB-231 cells, were selected for testing the novel system. A dual knock-out of ECM1 and PGRN was successfully achieved in MDA-MB-231 cell line, with the sgRNAs and Cas9 expression cassettes being removed by Cre. This system should have great potential in applications for multiple genes knock-out in vitro.
成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白(Cas)系统已被广泛用于基因敲除。慢病毒载体一直是该系统常用的递送方法,然而,由于慢病毒整合导致的Cas9/sgRNA长时间表达会导致脱靶突变不断积累。为了解决构建基因敲除细胞系中的这一问题,本研究建立了一种新型系统,该系统由两种慢病毒载体组成。一种慢病毒载体同时携带靶向单个或多个基因的sgRNA和CRISPR/Cas9表达盒;另一种慢病毒载体携带Cre,在实现基因靶向之后,Cre可去除基因组中多余的sgRNA和Cas9表达盒。为了验证该原理,选择了在MDA-MB-231细胞中高表达的两个候选基因,细胞外基质蛋白1(ECM1)和颗粒蛋白前体(PGRN),来测试该新型系统。在MDA-MB-231细胞系中成功实现了ECM1和PGRN的双敲除,sgRNA和Cas9表达盒被Cre去除。该系统在体外多个基因敲除的应用中应具有巨大潜力。